A combination of pertuzimab and Enhertu can slow disease progression and improve survival in people with HER2-positive ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, according to ...

Hyperprolactinaemia, often misunderstood, affects even non-pregnant women. Triggered by stress, medication, or tumours, it ...